PR Newswire09.12.18
Johnson & Johnson Medical Devices Companies,* through its subsidiary Johnson & Johnson Medical GmbH, announced the acquisition of Emerging Implant Technologies GmbH (EIT), a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany. The products in this portfolio leverage EIT’s proprietary advanced cellular titanium, which consists of an open and interconnected porous structure designed to allow bone to grow into the implant. As an industry leader across the full range of orthopedic and spine specialties, Johnson & Johnson Medical Devices Companies will leverage its global commercial infrastructure to bring EIT’s technologies to patients around the world.
This acquisition allows DePuy Synthes, the orthopedics business of Johnson & Johnson, to enhance its interbody implant portfolio that includes expandable interbody devices, titanium integrated PEEK technology and now 3D-printed cellular titanium, for both minimally invasive and open spinal surgery. The EIT technology complements DePuy Synthes’ investment in the interbody implant segment in spine, including the recent introductions of the CONCORDE LIFT Expandable Interbody Device, and in the United States, the PROTI 360° Family of Titanium-Integrated Interbody Implants, designed to treat patients with degenerative disc disease.
“Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients,” said Aldo Denti, company group chairman of DePuy Synthes. “We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes.”
Financial terms of the transaction were not disclosed.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world with solutions in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine.
As the world’s most comprehensive medical devices business, Johnson & Johnson Medical Devices Companies is building on a century of experience, leveraging science and technology, to shape the future of healthcare.
*The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, cardiovascular, and specialty solutions businesses within Johnson & Johnson’s Medical Devices segment.
This acquisition allows DePuy Synthes, the orthopedics business of Johnson & Johnson, to enhance its interbody implant portfolio that includes expandable interbody devices, titanium integrated PEEK technology and now 3D-printed cellular titanium, for both minimally invasive and open spinal surgery. The EIT technology complements DePuy Synthes’ investment in the interbody implant segment in spine, including the recent introductions of the CONCORDE LIFT Expandable Interbody Device, and in the United States, the PROTI 360° Family of Titanium-Integrated Interbody Implants, designed to treat patients with degenerative disc disease.
“Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients,” said Aldo Denti, company group chairman of DePuy Synthes. “We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes.”
Financial terms of the transaction were not disclosed.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world with solutions in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine.
As the world’s most comprehensive medical devices business, Johnson & Johnson Medical Devices Companies is building on a century of experience, leveraging science and technology, to shape the future of healthcare.
*The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, cardiovascular, and specialty solutions businesses within Johnson & Johnson’s Medical Devices segment.